OPTIMAL TIMING OF G-CSF ADMINISTRATION TO LIMIT THE SEVERITY AND DURATION OF NEUTROPENIA AND INFECTIONS COMPLICATIONS FOLLOWING MYELOSUPPRESSIVE CHEMOTHERAPY FOR CANCER IN CHILDREN
C. Bruggers et al., OPTIMAL TIMING OF G-CSF ADMINISTRATION TO LIMIT THE SEVERITY AND DURATION OF NEUTROPENIA AND INFECTIONS COMPLICATIONS FOLLOWING MYELOSUPPRESSIVE CHEMOTHERAPY FOR CANCER IN CHILDREN, Pediatric research, 39(4), 1996, pp. 903-903